Skip to main content



Professor with Tenure


Dr. Ed McKee is a biochemist specializing in mitochondrial metabolism and biogenesis and is an expert in the pedagogy of Team-Based-Learning. He joined CMED in 2011 as the Chair of Foundational Sciences and Professor of Biochemistry and Medical Genetics. He was appointed Interim Senior Associate Dean of Research, Administration, and Faculty Affairs in 2014 and Senior Associate Dean of Research in 2016; a position he still holds today. Dr. McKee teaches biochemistry and genetics throughout the curriculum and is currently a Co-Course Director of the Gastrointestinal Course. Edward McKee received B. S. degrees in Biology and Biochemistry from Pennsylvania State University in University Park, PA. He received his Ph. D. degree in physiology from the M. S. Hershey Medical Center, College of Medicine, Penn State University. His graduate work involved studies on the regulation of protein metabolism in the perfused rat heart. Following post-doctoral fellowships in the Department of Microbiology at the University of Connecticut Health Science Center in Farmington, Ct and in the Department of Molecular, Cellular, and Developmental Biology at the University of Colorado in Boulder, Dr. McKee took a faculty position in the Department of Biochemistry at what now is the Rosalind Franklin University of Health Science / The Chicago Medical School. Dr. McKee is active in the Team-Based Learning community and has given workshops on Team-Based learning at National and International meetings as well as at Universities and Medical Schools. He has served as treasurer and a member of the Executive committee of the Team Based Learning Collaborative. Dr. McKee also served as Vice-President of the Association of Biochemistry Educators (ABE), a group dedicated to supporting and enhancing the teaching of Biochemistry in medical, dental, and pharmacy schools. Dr. McKee's present laboratory research is on understanding the mitochondrial toxicity associated with several important classes of drugs. In a project funded by grants from the National Heart Lung and Blood Institute of the NIH, Dr. McKee’s laboratory studies the toxicity of anti-viral nucleoside analogs such as AZT used in the treatment of AIDS. In earlier work funded by pharmaceutical companies, Dr. McKee’s group studied the toxicity of antibiotics of the oxazolidinone family as represented by the FDA approved drug linezolid (Zyvox©).


Ph.D., Pennsylvania State University-College of Medicine, United States of America
B.S., Biochemistry, Pennsylvania State University,University Park, PA, United States of America